# Bioavailability of Flucanazole

> **NCT04502277** · EARLY_PHASE1 · UNKNOWN · sponsor: **Sutphin Drugs** · enrollment: 200 (estimated)

## Conditions studied

- Candidiasis

## Interventions

- **DRUG:** Fluconazole Powder

## Key facts

- **NCT ID:** NCT04502277
- **Lead sponsor:** Sutphin Drugs
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-01-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04502277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04502277, "Bioavailability of Flucanazole". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04502277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*